Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
17.02
+0.02 (0.12%)
Jul 7, 2026, 10:31 AM EDT - Market open
Surgery Partners Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,344 | 3,309 | 3,114 | 2,743 | 2,539 | 2,225 | |
Revenue Growth (YoY) | 5.38% | 6.24% | 13.52% | 8.03% | 14.12% | 19.62% |
Cost of Revenue | 2,580 | 2,544 | 2,369 | 2,096 | 1,964 | 1,734 |
Gross Profit | 763.3 | 765 | 745.6 | 647.5 | 574.9 | 491.4 |
Selling, General & Admin | 121.5 | 118.2 | 138.7 | 120.9 | 102.2 | 104 |
Depreciation & Amortization Expenses | 178.2 | 176 | 152.6 | 118.1 | 114.8 | 98.8 |
Other Operating Expenses | 70.2 | 81.3 | 105.5 | 80.5 | 12.7 | 24.3 |
Total Operating Expenses | 369.9 | 375.5 | 396.8 | 319.5 | 229.7 | 227.1 |
Operating Income | 393.4 | 389.5 | 348.8 | 328 | 345.2 | 302.2 |
Interest Income | 21.4 | 22.9 | 19.5 | 14.2 | 12.5 | 11.3 |
Interest Expense | -279.5 | -272.6 | -201.7 | -193 | -234.9 | -221 |
Other Non-Operating Income (Expense) | -21.4 | -22.9 | -19.5 | -14.2 | -12.5 | 26.6 |
Total Non-Operating Income (Expense) | -279.5 | -272.6 | -201.7 | -193 | -234.9 | -183.1 |
Pretax Income | 113.9 | 116.9 | 147.1 | 135 | 110.3 | 81.2 |
Provision for Income Taxes | 16.8 | 18 | 134.6 | -0.3 | 23.3 | 10.5 |
Net Income | 97.1 | 98.9 | 12.5 | 135.3 | 87 | 70.7 |
Minority Interest in Earnings | 173.2 | 176.8 | 180.6 | 147.2 | 141.6 | 141.6 |
Net Income Attributable to Preferred Dividends | - | - | - | - | - | -10.3 |
Net Income to Common | -76.1 | -77.9 | -168.1 | -11.9 | -54.6 | -152.1 |
Shares Outstanding (Basic) | 128 | 127 | 126 | 126 | 92 | 72 |
Shares Outstanding (Diluted) | 128 | 127 | 126 | 126 | 92 | 72 |
Shares Change (YoY) | 1.08% | 0.86% | 0.40% | 36.61% | 26.96% | 48.49% |
EPS (Basic) | -0.60 | -0.61 | -1.33 | -0.09 | -0.59 | -1.12 |
EPS (Diluted) | -0.60 | -0.61 | -1.33 | -0.09 | -0.59 | -1.12 |
Free Cash Flow | 208 | 195.6 | 209.7 | 205 | 78.2 | 29.5 |
Free Cash Flow Growth | 6.34% | -6.72% | 2.29% | 162.15% | 165.08% | -85.54% |
Free Cash Flow Per Share | 1.63 | 1.54 | 1.66 | 1.63 | 0.85 | 0.41 |
Gross Margin | 22.83% | 23.12% | 23.94% | 23.60% | 22.64% | 22.08% |
Operating Margin | 11.77% | 11.77% | 11.20% | 11.96% | 13.59% | 13.58% |
Profit Margin | 2.90% | 2.99% | 0.40% | 4.93% | 3.43% | 3.18% |
FCF Margin | 6.22% | 5.91% | 6.73% | 7.47% | 3.08% | 1.33% |
EBITDA | 571.6 | 565.5 | 501.4 | 446.1 | 460 | 401 |
EBITDA Margin | 17.10% | 17.09% | 16.10% | 16.26% | 18.12% | 18.02% |
EBIT | 393.4 | 389.5 | 348.8 | 328 | 345.2 | 302.2 |
EBIT Margin | 11.77% | 11.77% | 11.20% | 11.96% | 13.59% | 13.58% |
Effective Tax Rate | 14.75% | 15.40% | 91.50% | -0.22% | 21.12% | 12.93% |